Clinical trial
A Trial of MitoQ for the Treatment of People With Parkinson's Disease
NCT00329056 · Antipodean Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00329056 |
|---|---|
| Title | A Trial of MitoQ for the Treatment of People With Parkinson's Disease |
| Official title | A Double-Blind, Prospective, Randomized Comparison of 2 Doses of MitoQ and Placebo for the Treatment of Patients With Parkinson's Disease |
| Lead sponsor | Antipodean Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | MitoQ |
| Enrollment | 128 |
| Start date | May 1, 2006 |
| Completion | Nov 1, 2007 |
| First posted | May 24, 2006 |
| Last update posted | Jul 21, 2010 |
| Countries | Australia, New Zealand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: